Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by University of Sao Paulo.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Northwestern University
Genzyme, a Sanofi Company
Information provided by:
University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT00315133
First received: April 13, 2006
Last updated: November 15, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by University of Sao Paulo

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):